GC
BMY icon

Gould Capital’s Bristol-Myers Squibb BMY Stock Holding History

Gould Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-160
Closed -$9.72K – 218
2026
Q1 		$9.72K Hold
160
– – 0.01% 136
2025
Q4 		$8.64K Hold
160
– – 0.01% 145
2025
Q3 		$7.23K Buy
160
+60
+60% +$2.8K ﹤0.01% 153
2025
Q2 		$4.64K Hold
100
– – ﹤0.01% 164
2025
Q1 		$6.12K Hold
100
– – ﹤0.01% 153
2024
Q4 		$5.67K Sell
100
-1
-1% -$56 ﹤0.01% 156
2024
Q3 		$5.24K Buy
101
+1
+1% +$47 ﹤0.01% 162
2024
Q2 		$4.15K Hold
100
– – ﹤0.01% 170
2024
Q1 		$5.42K Buy
+100
New +$5.09K ﹤0.01% 162

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Gould Capital's BMY Position: Q2 2026 in Review

Gould Capital sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 160 shares — an estimated $9.72K sold.

Gould Capital first reported a position in BMY in Q1 2024 and held it in 9 quarters. The position peaked at $9.72K in Q1 2026. 2,519 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Gould Capital reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
  • Gould Capital sold 160 Bristol-Myers Squibb shares in Q2 2026, an estimated $9.72K.
  • Gould Capital first reported a position in Bristol-Myers Squibb in Q1 2024 and held it in 9 quarters.
  • Gould Capital's Bristol-Myers Squibb position peaked at $9.72K in Q1 2026.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Gould Capital's 13F filing for Q2 2026, filed 7 Aug 2026.